AOD 9604 (Anti-Obesity Drug): This peptide specifically targets fat metabolism and is designed to help with weight loss without affecting blood sugar levels or appetite
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The three essentials for running any reconstituted injectable: cold storage, accurate syringes, and metabolic tracking
No, there is no scientific evidence that B12 injections promote fat loss in individuals with normal B12 levels
Wang, Y., Kory, N., BasuRay, S., Cohen, J